Key Findings on GLP-1 Use in MS
GLP-1 receptor agonists (e.g., Ozempic, Wegovy) show potential in multiple sclerosis (MS) as potential neuroprotective, anti-inflammatory, and weight-loss agents. Preclinical studies…
Categories
Latest Blog Posts
- Comprehensive Guide to Bladder Dysfunction in MS
- The Surprising Side Effect She Didn’t Dare Talk About
- Incidentalomas in Multiple Sclerosis
- How to Treat MS Pain
- Wheelchair Fit for Function and Support
- Scientists Find New Evidence Linking Epstein-Barr Virus to MS
- MS Study Alert: How Can We Prevent Falls in People Who Use Wheelchairs? Researchers Recruiting for Two Studies
- New Study Points to Racial and Ethnic Differences in MS-Related Deaths
- For Your Loved Ones
- Heat Sensitivity With Multiple Sclerosis
- Driving rehabilitation program
- Top 5 Ways to Relieve OsteoArthritis Pain
- Top 5 Ways to Relieve Arthritis Pain
- B-Cell Depletion Recruits Protective Gut Cells in MS
- What Is the Nordic Diet? A Detailed Beginner’s Guide
- MS Flare vs. Pseudo-Relapse: How Heat, Infection, and Stress Can Mimic a Relapse
- Nasal MS therapy moves closer to results after final patient dosed
- Caregivers are like human assistive devices, but with feelings
- MS Takes a Toll on Caregivers, Too, Especially on Their Mental Health
- An MS caregiver’s dilemma: Do I stay or do I go?
